Compare RXST & HFRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RXST | HFRO |
|---|---|---|
| Founded | 1997 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.3M | 362.0M |
| IPO Year | 2021 | N/A |
| Metric | RXST | HFRO |
|---|---|---|
| Price | $12.72 | $6.10 |
| Analyst Decision | Hold | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $11.30 | N/A |
| AVG Volume (30 Days) | ★ 875.0K | 179.8K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.87% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $142,085,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.18 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 10.75 | N/A |
| 52 Week Low | $6.32 | $4.24 |
| 52 Week High | $44.22 | $6.45 |
| Indicator | RXST | HFRO |
|---|---|---|
| Relative Strength Index (RSI) | 75.78 | 42.29 |
| Support Level | $11.20 | $5.95 |
| Resistance Level | $10.12 | $6.17 |
| Average True Range (ATR) | 0.70 | 0.21 |
| MACD | 0.23 | 0.00 |
| Stochastic Oscillator | 89.45 | 40.85 |
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
Highland Opportunities and Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to Income Fund seeks growth of capital along with income. It focuses on making investments in real estate securities, including Reits, secured and unsecured fixed-rate loans and corporate bonds, mezzanine securities, structured products, convertible and preferred securities and equities (public and private), and floating rate securities.